(Georgia Institute of Technology, 2012-09-13)
Mooney, David J.
There are hundreds of clinical trials of cell therapy currently underway, but simple cell infusions
lead to large-scale cell death, little control over cell fate, and a typically poor clinical outcome.
We propose biomaterials to first serve as cell carriers or attractors of host cell populations, and
then serve to program the cells in vivo and ultimately disperse the cells to participate in
regeneration or immunotherapy.
(Georgia Institute of Technology, 2011-09-20)
Suresh, Subra
Major advances in various branches of engineering and natural sciences, together with
transformational developments in information technology, computational modeling and simulation,
genetics, genomics, and nanotechnology, have provided unprecedented opportunities to explore
human health and diseases at the cellular and molecular levels. Such developments have also
facilitated new opportunities to study fundamental mechanistic processes with the goal of
developing basic scientific understanding, new diagnostic tools, and novel therapeutics for a
range of human diseases and disorders. This presentation will provide an overview of some
recent accomplishments and opportunities for future exploration. Specific examples are drawn
from the study of infectious diseases, hereditary blood disorders, and cancer.